Post-approval studies (Phase 4)Study completedNCT04137510What this trial is testingBioflow-DAPT StudyWho this might be right forCoronary Artery Disease Biotronik AG 1,948
Post-approval studies (Phase 4)UnknownNCT03462498What this trial is testingShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACSWho this might be right forAcute Coronary SyndromeAcute Myocardial InfarctionCoronary Artery Disease+2 more Kyoto University, Graduate School of Medicine 3,008
Not applicableLooking for participantsNCT06223607What this trial is testingDual Antiplatelet Therapy (DAPT) in Patients With Baseline ThrombocytopeniaWho this might be right forBaseline Thrombocytopenia Methodist Health System 300
Not applicableStudy completedNCT03218787What this trial is testingXIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.Who this might be right forCoronary Artery Lesions Abbott Medical Devices 2,047
Not applicableNot Yet RecruitingNCT07140133What this trial is testingDual Anti-Platelet Optimized Stent for High Bleeding Risk PatientWho this might be right forHigh Bleeding Risk PatientsCardiologyStent Implantation+1 more University Hospital, Grenoble 1,200
Not applicableLooking for participantsNCT05785897What this trial is testingSTEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPTWho this might be right forST Elevation Myocardial Infarction IGLESIAS Juan Fernando 350
Post-approval studies (Phase 4)Study completedNCT01995370What this trial is testingCilostazol Stroke Prevention Study for Antiplatelet CombinationWho this might be right forNoncardioembolic Cerebral Infarction Japan Cardiovascular Research Foundation 1,884
Post-approval studies (Phase 4)Not Yet RecruitingNCT07592507What this trial is testing1 or 6 Months of Dual Antiplatelet Therapy After Drug-coated Balloon Angioplasty for De-novo Small Coronary Artery DiseaseWho this might be right forStable Angina PectorisCoronary Artery Disease Daejeon St. Mary's hospital 1,484
Post-approval studies (Phase 4)Ended earlyNCT03119012What this trial is testingP2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable ScaffoldWho this might be right forCoronary Artery DiseaseStentsAtherosclerosis Samsung Medical Center 25
Not applicableEnded earlyNCT05071027What this trial is testingDual Antiplatelet Therapy Adherence With Reminder App UsageWho this might be right forAneurysm Cerebral (Unruptured) Montefiore Medical Center 9
Post-approval studies (Phase 4)Study completedNCT03284827What this trial is testingAnticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve ReplacementWho this might be right forAortic Valve Stenosis Duk-Woo Park, MD 235
Post-approval studies (Phase 4)Looking for participantsNCT06718179What this trial is testingComparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting StentsWho this might be right forAcute Coronary Syndrome Odense University Hospital 3,150
Very early researchNot Yet RecruitingNCT06339021What this trial is testingOCT or Angiography Guided De-escalation of DAPTWho this might be right forOptical Coherence TomographyDual Antiplatelet TherapyAntiplatelet De-escalation+2 more Shenyang Northern Hospital 80
Not applicableNot Yet RecruitingNCT07125651What this trial is testingGastrointestinal Bleeding is Blood Loss in the Digestive Tract, Classified as Upper or Lower. Ischemic Heart Disease is Due to Blocked Heart Arteries. Antiplatelet Drugs Help Prevent Heart Attacks But Increase GI Bleeding Risk, Especially When Used Together as Dual Therapy.Who this might be right forGastro Intestinal BleedingIschaemic Heart DiseasesAntiplatelet Drugs+1 more Assiut University 112
Not applicableStudy completedNCT05750758What this trial is testingRivaroxaban Combined With DAPT Versus DAPT Alone After Drug-coated Balloon AngioplastyWho this might be right forAcute Coronary Syndrome Henan Institute of Cardiovascular Epidemiology 140
Not applicableUnknownNCT01701453What this trial is testingSafety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE)Who this might be right forAcute Coronary Syndrome Samsung Medical Center 2,712
Post-approval studies (Phase 4)UnknownNCT03103685What this trial is testingContinue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.Who this might be right forDental DiseasesAntiplatelet AgentsAntiplatelet Drugs Chiang Mai University 428
Post-approval studies (Phase 4)Study completedNCT03431142What this trial is testingOptimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients TrialWho this might be right forProlonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage Shenyang Northern Hospital 7,758
Not applicableStudy completedNCT05487560What this trial is testingAn Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal BleedingWho this might be right forAcute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months Hanmi Pharmaceutical Company Limited 4,133
Post-approval studies (Phase 4)Looking for participantsNCT07507500What this trial is testingDual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 MonthsWho this might be right forMyocardial Infarction (MI) Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 8,100